Back
First Tr Morningstar Dividend Leaders Index Fund Vs. Novo Nordisk AS Industry Stock Comparison
Sell
34
FDL
First Tr Morningstar Dividend Leaders Index Fund
Last Price:
$40.18
Seasonality Move:
-1.81%
Sell
23
NVO
Novo Nordisk AS
Last Price:
$85.00
Seasonality Move:
6.92%
Sell
34
First Tr Morningstar Dividend Leaders Index Fund (FDL)
is a Sell
Is First Tr Morningstar Dividend Leaders Index Fund a Buy, Sell or Hold?
-
The current First Tr Morningstar Dividend Leaders Index Fund [FDL] share price is $40.17. The Score for FDL is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
FDL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FDL Stock Price Chart
What is First Tr Morningstar Dividend Leaders Index Fund's stock price today?
-
The First Tr Morningstar Dividend Leaders Index Fund share price today is $40.17Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDL is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $85.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.
FDL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.64 | Sell |
Relative Strength Index (14 RSI): | 31.36 | Sell |
Chaikin Money Flow: | 393190 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.06 - 43.5) | Sell |
Bollinger Bands (100): | (40.59 - 42.67) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.5 | Sell |
Relative Strength Index (14 RSI): | 19.69 | Sell |
Chaikin Money Flow: | 20899665 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (100.63 - 110.99) | Sell |
Bollinger Bands (100): | (107.27 - 131.41) | Sell |
FDL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.81 | Sell |
20-day SMA: | 42.26 | Sell |
50-day SMA: | 42.21 | Sell |
200-day SMA: | 39.91 | Buy |
8-day EMA: | 40.73 | Sell |
20-day EMA: | 41.61 | Sell |
50-day EMA: | 41.91 | Sell |
200-day EMA: | 40.11 | Buy |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 104.71 | Sell |
20-day SMA: | 106.65 | Sell |
50-day SMA: | 109.28 | Sell |
200-day SMA: | 126.25 | Sell |
8-day EMA: | 102.07 | Sell |
20-day EMA: | 105.53 | Sell |
50-day EMA: | 110.02 | Sell |
200-day EMA: | 118.09 | Sell |
First Tr Morningstar Dividend Leaders Index Fund Earnings Growth & FDL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.66 per share.
First Tr Morningstar Dividend Leaders Index Fund Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |